• español
  • English
  • français
  • Deutsch
  • português (Brasil)
  • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Stöbern

    Gesamter BestandBereicheErscheinungsdatumAutorenSchlagwortenTiteln

    Mein Benutzerkonto

    Einloggen

    Statistik

    Benutzungsstatistik

    Compartir

    Dokumentanzeige 
    •   UVaDOC Startseite
    • WISSENSCHAFTLICHE ARBEITEN
    • Departamentos
    • Dpto. Bioquímica y Biología Molecular y Fisiología
    • DEP06 - Artículos de revista
    • Dokumentanzeige
    •   UVaDOC Startseite
    • WISSENSCHAFTLICHE ARBEITEN
    • Departamentos
    • Dpto. Bioquímica y Biología Molecular y Fisiología
    • DEP06 - Artículos de revista
    • Dokumentanzeige
    • español
    • English
    • français
    • Deutsch
    • português (Brasil)
    • italiano

    Exportar

    RISMendeleyRefworksZotero
    • edm
    • marc
    • xoai
    • qdc
    • ore
    • ese
    • dim
    • uketd_dc
    • oai_dc
    • etdms
    • rdf
    • mods
    • mets
    • didl
    • premis

    Citas

    Por favor, use este identificador para citar o enlazar este ítem:https://uvadoc.uva.es/handle/10324/73938

    Título
    Advanced nanomedicine and cancer: Challenges and opportunities in clinical translation
    Autor
    González Valdivieso, JuanAutoridad UVA Orcid
    Girotti ., AlessandraAutoridad UVA Orcid
    Schneider, Jose
    Arias Vallejo, Francisco JavierAutoridad UVA Orcid
    Año del Documento
    2021
    Editorial
    Elsevier
    Descripción
    Producción Científica
    Documento Fuente
    International Journal of Pharmaceutics, April 2021, vol. 599, 120438
    Zusammenfassung
    Cancer has reached pandemic dimensions in the whole world. Although current medicine offers multiple treatment options against cancer, novel therapeutic strategies are needed due to the low specificity of chemotherapeutic drugs, undesired side effects and the presence of different incurable types of cancer. Among these new strategies, nanomedicine arises as an encouraging approach towards personalized medicine with high potential for present and future cancer patients. Therefore, nanomedicine aims to develop novel tools with wide potential in cancer treatment, imaging or even theranostic purposes. Even though numerous preclinical studies have been published with successful preliminary results, promising nanosystems have to face multiple obstacles before adoption in clinical practice as safe options for patients with cancer. In this MiniReview, we provide a short overview on the latest advances in current nanomedicine approaches, challenges and promising strategies towards more accurate cancer treatment.
    Palabras Clave
    Cancer
    Nanomedicine
    Chemotherapy
    Drug delivery
    Nanodrugs
    ISSN
    0378-5173
    Revisión por pares
    SI
    DOI
    10.1016/j.ijpharm.2021.120438
    Patrocinador
    Ministerio de Ciencia, Innovación y Universidades (PID2019-106386RB-I00)
    CIBER-BBN (DTS19/00162)
    Version del Editor
    https://www.sciencedirect.com/science/article/pii/S0378517321002428
    Propietario de los Derechos
    © 2021 Elsevier
    Idioma
    eng
    URI
    https://uvadoc.uva.es/handle/10324/73938
    Tipo de versión
    info:eu-repo/semantics/submittedVersion
    Derechos
    openAccess
    Aparece en las colecciones
    • DEP06 - Artículos de revista [352]
    Zur Langanzeige
    Dateien zu dieser Ressource
    Nombre:
    advanced-nanomedicine-cancer-challenges-opportunities_preprint.pdf
    Tamaño:
    434.2Kb
    Formato:
    Adobe PDF
    Thumbnail
    Öffnen
    Attribution-NonCommercial-NoDerivatives 4.0 InternacionalSolange nicht anders angezeigt, wird die Lizenz wie folgt beschrieben: Attribution-NonCommercial-NoDerivatives 4.0 Internacional

    Universidad de Valladolid

    Powered by MIT's. DSpace software, Version 5.10